Tetratherix, which focuses on post-surgery skin healing, eyes new product: Nasal Ozempic

The Market Herald

Mar 16

Tetratherix (ASX:TTX) is pivoting into one interesting class of biotech product well outside its existing focus on skin healing product TetraDerm for use following surgery – it wants to bring nasal ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2619570484"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2619570484\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2619570484?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 08:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619570484","market":"nz","top_or_hot":-1,"title":"Tetratherix, which focuses on post-surgery skin healing, eyes new product: Nasal Ozempic","media":"The Market Herald","content":"<div>\n<p>Tetratherix (ASX:TTX) is pivoting into one interesting class of biotech product well outside its existing focus on skin healing product TetraDerm for use following surgery – it wants to bring nasal ...</p>\n\n<a href=\"https://themarketonline.com.au/tetratherix-which-focuses-on-post-surgery-skin-healing-eyes-new-product-nasal-ozempic-2026-03-16/\">Source Link</a>\n\n</div>\n","source":"markerherald_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tetratherix, which focuses on post-surgery skin healing, eyes new product: Nasal Ozempic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTetratherix, which focuses on post-surgery skin healing, eyes new product: Nasal Ozempic\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-16 08:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://themarketonline.com.au/tetratherix-which-focuses-on-post-surgery-skin-healing-eyes-new-product-nasal-ozempic-2026-03-16/><strong>The Market Herald</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tetratherix (ASX:TTX) is pivoting into one interesting class of biotech product well outside its existing focus on skin healing product TetraDerm for use following surgery – it wants to bring nasal ...</p>\n\n<a href=\"https://themarketonline.com.au/tetratherix-which-focuses-on-post-surgery-skin-healing-eyes-new-product-nasal-ozempic-2026-03-16/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TTX.AU","symbol_name":"Tetratherix Ltd","start_time":0,"source_url":"https://themarketonline.com.au/tetratherix-which-focuses-on-post-surgery-skin-healing-eyes-new-product-nasal-ozempic-2026-03-16/","article_id":"2619570484","we_media_id":null,"thumbnails":[],"rights":{"source":"markerherald_stock","url":"https://themarketonline.com.au/tetratherix-which-focuses-on-post-surgery-skin-healing-eyes-new-product-nasal-ozempic-2026-03-16/","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2619570484","pubTimestamp":1773621780,"columns":[],"sourceInfo":{"source_id":"markerherald_stock","name":"The Market Herald"},"weMediaInfo":null,"summary":"Tetratherix  is pivoting into one interesting class of biotech product well outside its existing focus on skin healing product TetraDerm for use following surgery – it wants to bring nasal GLP-1 drugs to market.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week.On Spotify, Apple, and more.If that sounds familiar, yes, we’re talking about the class of drugs that Ozempic made famous – next-gen weight loss medication that doesn’t involve anything that boosts your heart rate. And Tetratherix wants to make it a nasal delivery system. In other words, Ozempic for the nose.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.","collect":0,"end_time":0,"defaultTopTitle":"themarketonline.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"TTX.AU":"Tetratherix Ltd","BK7067":"生物科技"},"translate_title":"专注于术后皮肤愈合的Tetratherix推出新产品：Nasal Ozempic","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TTX.AU":1},"content_text":"Tetratherix (ASX:TTX) is pivoting into one interesting class of biotech product well outside its existing focus on skin healing product TetraDerm for use following surgery – it wants to bring nasal GLP-1 drugs to market.\nListen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.\nIf that sounds familiar, yes, we’re talking about the class of drugs that Ozempic made famous – next-gen weight loss medication that doesn’t involve anything that boosts your heart rate. And Tetratherix wants to make it a nasal delivery system. In other words, Ozempic for the nose.\nIn a stab at going for synthesis, the company put to the market that the GLP-1 nasal delivery system will use Tetratherix’s existing “Tetramatrix platform polymer,” but at the end of the day, it’s a skin healing company going into nasal weight loss drugs. \nThat can’t be denied. But it wasn’t something the Australian market balked at. In fact, investors were obviously bullish. As of 11am SYD, Tetratherix is up +18% to $4.91; close to record levels at $5.30/sh in October last year when the materials sector (and anything else that had hype) went gangbusters.\nTetratherix was at one point the most successful IPO of last year; it listed in June 2025 at $3, hit $5.20/sh in July, and climbed above that again in October.\n(Between those peaks was a decent amount of churn; between December and January, there was something of a valley of despair.)\n\nTetratherix’s 1Y chart (Market Index)\nSo, now where to from here for Tetratherix? That’s hard to tell, but we can expect the Aussie company to probably do more work here, further explaining to its many investors the larger story behind this pivot. \nRight now, that’s only known by those in the know. \nTTX last traded at $4.91/sh. \nJoin the discussion: See what HotCopper users are saying about Tetratherix Ltd and be part of the conversations that move the markets.\nThe material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}